Biologika, L.l.c. - Net Worth and Insider Trading

Biologika, L.l.c. Net Worth

The estimated net worth of Biologika, L.l.c. is at least $6 Million dollars as of 2024-05-13. Biologika, L.l.c. is the 13(d) group member, owns > 10% of Emergent BioSolutions Inc and owns about 1,375,084 shares of Emergent BioSolutions Inc (EBS) stock worth over $6 Million. Details can be seen in Biologika, L.l.c.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Biologika, L.l.c. has not made any transactions after 2006-11-14 and currently still holds the listed stock(s).

Transaction Summary of Biologika, L.l.c.

To

Biologika, L.l.c. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Biologika, L.l.c. owns 1 companies in total, including Emergent BioSolutions Inc (EBS) .

Click here to see the complete history of Biologika, L.l.c.’s form 4 insider trades.

Insider Ownership Summary of Biologika, L.l.c.

Ticker Comapny Transaction Date Type of Owner
EBS Emergent BioSolutions Inc 2006-11-14 other: 13(d) group member & owns > 10%

Biologika, L.l.c. Latest Holdings Summary

Biologika, L.l.c. currently owns a total of 1 stock. Biologika, L.l.c. owns 1,375,084 shares of Emergent BioSolutions Inc (EBS) as of November 14, 2006, with a value of $6 Million.

Latest Holdings of Biologika, L.l.c.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
EBS Emergent BioSolutions Inc 2006-11-14 1,375,084 4.35 5,981,615

Holding Weightings of Biologika, L.l.c.


Biologika, L.l.c. Form 4 Trading Tracker

According to the SEC Form 4 filings, Biologika, L.l.c. has made a total of 0 transactions in Emergent BioSolutions Inc (EBS) over the past 5 years. The most-recent trade in Emergent BioSolutions Inc is the sale of 0 shares on November 14, 2006, which brought Biologika, L.l.c. around $0.

Insider Trading History of Biologika, L.l.c.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Biologika, L.l.c. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Biologika, L.l.c. Ownership Network

Ownership Network List of Biologika, L.l.c.

No Data

Ownership Network Relation of Biologika, L.l.c.


Biologika, L.l.c. Owned Company Details

What does Emergent BioSolutions Inc do?

Who are the key executives at Emergent BioSolutions Inc?

Biologika, L.l.c. is the other: 13(d) group member & owns > 10% of Emergent BioSolutions Inc. Other key executives at Emergent BioSolutions Inc include SVP & Bioservices William Hartzel , Interim CEO Miller H Haywood Iii , and SVP & Products Business Paul Anthony Williams .

Emergent BioSolutions Inc (EBS) Insider Trades Summary

Over the past 18 months, Biologika, L.l.c. made no insider transaction in Emergent BioSolutions Inc (EBS). Other recent insider transactions involving Emergent BioSolutions Inc (EBS) include a net sale of 3,530 shares made by Kathryn C Zoon , and a net sale of 1,912 shares made by Ronald Richard .

In summary, during the past 3 months, insiders sold 0 shares of Emergent BioSolutions Inc (EBS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 5,442 shares of Emergent BioSolutions Inc (EBS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 5,442 shares.

Emergent BioSolutions Inc (EBS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Emergent BioSolutions Inc Insider Transactions

No Available Data

Biologika, L.l.c. Mailing Address

Above is the net worth, insider trading, and ownership report for Biologika, L.l.c.. You might contact Biologika, L.l.c. via mailing address: 11308 Glen Rd., Potomac Md 20854.

Discussions on Biologika, L.l.c.

No discussions yet.